Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention-Reference-Cited by-同舟云学术

Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention

Published:2018-10-27 Issue:3 Volume:173 Page:559-571
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Walter Katherine R.,Ford Marvella E.,Gregoski Mathew J.,Kramer Rita M.,Knight Kendrea D.,Spruill Laura,Nogueira Lourdes M.,Krisanits Bradley A.,Phan Van,La Rue Amanda C.,Lilly Michael B.,Ambs Stefan,Chan King,Turner Tonya F.,Varner Heidi,Singh Shweta,Uribarri Jaime,Garrett-Mayer Elizabeth,Armeson Kent E.,Hilton Ebony J.,Clair Mark J.,Taylor Marian H.,Abbott Andrea M.,Findlay Victoria J.,Peterson Lindsay L.,Magwood Gayenell,Turner David P.^ORCID

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-018-4992-7/fulltext.html

Reference28 articles.

1. Singh R, Barden A, Mori T, Beilin L (2001) Advanced glycation end-products: a review. Diabetologia 44(2):129–146. https://doi.org/10.1007/s001250051591

2. Ansari NA, Rasheed Z (2010) Non-enzymatic glycation of proteins: from diabetes to cancer. Biomed Khim 56(2):168–178

3. Cho SJ, Roman G, Yeboah F, Konishi Y (2007) The road to advanced glycation end products: a mechanistic perspective. Curr Med Chem 14(15):1653–1671